Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806479 · ClinicalTrials.gov registry record
Hypertrophic Cardiomyopathy Pilot Study
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 40
- Enrollment target
NCT02806479: Completed study, sponsored by Oregon Health and Science University.
NCT02806479 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806479 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate
Interventions
- OTHER Observational: Arrhythmogenic Substrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-09 |
What the finished NCT02806479 record still lists
NCT02806479 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational: Arrhythmogenic Substrate is the first listed.
NCT02806479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02806479 about?
NCT02806479 is a clinical study titled "Hypertrophic Cardiomyopathy Pilot Study". This study evaluates mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy, in comparison to patients with well-understood arrhythmogenic substrate (ischemic cardiomyopathy), as well as to individuals free from arrhythmogenic substrate
What is the current status of trial NCT02806479?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-09. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02806479?
The interventions under investigation include: Observational: Arrhythmogenic Substrate (OTHER).
Who is sponsoring clinical trial NCT02806479?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia